The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Cardiovascular Disease Rate Differs Between SLE Patients of Different Races, Ethnicities

Cardiovascular Disease Rate Differs Between SLE Patients of Different Races, Ethnicities

December 18, 2017 • By Kurt Ullman

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Dr. Barbhaiya

Dr. Barbhaiya

A recent epidemiologic study of patients with systemic lupus erythematosus (SLE) investigated racial and ethnic differences in the risk for cardiovascular disease (CVD). Among SLE patients enrolled in Medicaid, the risk for myocardial infarction (MI) was lower in Hispanics and Asians compared with whites, and the risk of stroke was higher in blacks and Hispanics compared with whites.1

You Might Also Like
  • SLE Patients May Not Receive Enough Cardiovascular Disease Assessment & Treatment
  • Newly Diagnosed SLE Patients Have a Greater Risk of Cardiovascular Disease
  • Biomarkers, Genetic Clues to Higher Cardiovascular Disease Risk in Patients with Lupus
Explore This Issue
December 2017
Also By This Author
  • Mouse Research Suggests the Microbiome Is Related to Lupus

“The risk of CVD is known to be greatly elevated among SLE patients and is the major cause of death in SLE,” says Medha Barbhaiya, MD, MPH, an assistant attending physician at the Hospital for Special Surgery and an assistant professor at Weill Cornell Medical College in New York City. “It is also known that Hispanic, Asian and African Americans in the United States have higher incidence of SLE than whites, and often more severe disease. However, the role of patient race and ethnicity in relation to risk of CVD previously has not been well understood.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Study

The researchers used the Medicaid Analytic eXtract to identify patients between 18 and 65 years old with an SLE diagnosis and at least 12 months of continuous enrollment. The study ran from 2000–2010. The researchers followed the subjects from their SLE index date to their first CVD event, MI or stroke (if any), or death, dis­enrollment, loss to follow-up or end of the follow-up period. Of the 65,788 SLE patients enrolled, 93% were women, roughly 42% were black, 48% were white, 16% were Hispanic, 3% were Asian, and 1% were Native American/Alaskan Native. The mean follow-up time was 3.8 years.

CVD rates were highest among blacks, with an incidence rate (IR) of 10.57, and lowest among Asians, with an IR of 6.63. After multivariable adjustment, the risk of CVD events was elevated among blacks, with a hazard ratio (HR) of 1.14, compared with whites. When examining MI or stroke risk separately, Hispanics and Asians had a lower risk, with an HR of 0.61 and 0.57, respectively, compared with white SLE patients enrolled in Medicaid. Blacks and Hispanics had a higher risk for stroke than whites, with an HR of 1.31 and 1.22, respectively. Among all patients, the annual CVD event IR per 1,000 person-years measured 9.31. All rates came with a 95% CI.

A recent epidemiologic study of patients with SLE investigated racial and ethnic differences in the risk for cardiovascular disease.

A recent epidemiologic study of patients with SLE investigated racial and ethnic differences in the risk for cardiovascular disease.
Rawpixel.com / SHUTTERSTOCK.COM

Pages: 1 2 3 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: ACR Journal, African American, American College of Rheumatology, Asian, Cardiovascular disease, comorbidities, ethnicities, heart, Hispanic, Lupus, Myocardial infarction, outcome, patient care, race, Research, rheumatologist, rheumatology, risk, stroke, study, Systemic lupus erythematosus, whiteIssue: December 2017

You Might Also Like:
  • SLE Patients May Not Receive Enough Cardiovascular Disease Assessment & Treatment
  • Newly Diagnosed SLE Patients Have a Greater Risk of Cardiovascular Disease
  • Biomarkers, Genetic Clues to Higher Cardiovascular Disease Risk in Patients with Lupus
  • Insight into Endothelial Dysfunction in Early SLE Patients without Cardiovascular Disease

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)